sábado, 4 de abril de 2015

New Guide: Medication-Assisted Treatment for Alcohol Use Disorder

New Guide: Medication-Assisted Treatment for Alcohol Use Disorder



SAMHSA
New Guidance on Medication-Assisted Treatment for Alcohol Use Disorder
Brief Document
SAMHSA has released a new guide for expanding the use of medication in clinical practice for the treatment of alcohol use disorder: Medication for the Treatment of Alcohol Use Disorder—A Brief Guide.
The guide was created in partnership with the National
Institute on Alcohol Abuse and Alcoholism by convening a panel composed of experts in research, clinical care, medical education, and public policy. It summarizes information on the four medications approved by the U.S. Food and Drug Administration (FDA) to treat alcohol use disorder, prevent relapse to alcohol use, or both. The FDA-approved medications are disulfiram, oral naltrexone, extended-release injectable naltrexone, and acamprosate.
The new guide addresses six key topics:
  • Considering medications based on FDA-approved indications and a patient's unique needs and circumstances
  • Screening a patient for risky alcohol use
  • Assessing need for medication-assisted treatment
  • Developing a treatment plan and selecting a medication
  • Treating a patient with co-occurring disorders
  • Monitoring a patient's progress.

No hay comentarios:

Publicar un comentario